Global Nav

Call 1-888-805-4555 for 24/7 on-call assistance

Indication and Important Safety Information
U.S. full Prescribing Information, including Boxed WARNINGS

ABECMA® (idecabtagene vicleucel) Suspension for IV Infusion

Please see relevant codes for ABECMA below

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb makes no guarantee regarding reimbursement for any service or item.

INDICATION

ABECMA (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.

 

APC=Ambulatory Payment Classification; ASP=average sales price; CAR=chimeric antigen receptor; CMS=Centers for Medicare and Medicaid Services; CPT=Current Procedural Terminology; CY=calendar year; FFS=fee-for-service: FY=fiscal year; HCPCS=Healthcare Common Procedure Coding System; ICD-10-CM=International Classification of Diseases, Tenth Revision, Clinical Modification; ICD-20-PCS=lnternational Classification of Diseases, Tenth Revision, Procedure Coding System; IPPS=lnpatlent Prospective Payment System; IV=intravenous; MAC=Medicare Administrative Contractor; MS-DRG=Medicare Severity Diagnosis Related Group; NDC=National Drug Code; PA=prior authorization; PFS=physician fee schedule; REMS=Risk Evaluation and Mitigation Strategy; WAC=wholesale acquisition cost.

ONLINE RESOURCES
Blank CMS 1450 and CMS 1500 claim forms can be found at CMS.gov.

DOWNLOADABLE RESOURCES
ABECMA PA submission tip sheet
ABECMA codes and sample claim forms

This information is provided for educational purposes only. Bristol Myers Squibb cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care and is subject to frequent change. It is the sole responsibility of the healthcare provider to select the proper codes and ensure the accuracy of all statements used in seeking coverage and reimbursement for an individual patient.